0000899243-22-010796.txt : 20220311
0000899243-22-010796.hdr.sgml : 20220311
20220311210023
ACCESSION NUMBER: 0000899243-22-010796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Astle Christopher
CENTRAL INDEX KEY: 0001915257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38068
FILM NUMBER: 22734889
MAIL ADDRESS:
STREET 1: 114 EAST 4TH AVENUE, SUITE 800
CITY: VANCOUVER
STATE: A1
ZIP: V5T 1G4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymeworks Inc.
CENTRAL INDEX KEY: 0001403752
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
BUSINESS PHONE: (604) 678-1388
MAIL ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
FORMER COMPANY:
FORMER CONFORMED NAME: Zymeworks Inc
DATE OF NAME CHANGE: 20070620
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-10
0
0001403752
Zymeworks Inc.
ZYME
0001915257
Astle Christopher
C/O ZYMEWORKS INC.
114 EAST 4TH AVENUE, SUITE 800
VANCOUVER
A1
V5T 1G4
BRITISH COLUMBIA, CANADA
0
1
0
0
SVP & Chief Financial Officer
Stock Option (Right to Buy)
7.00
2022-03-10
4
A
0
125000
0.00
A
2032-03-09
Common Shares
125000
125000
D
Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
/s/ Daniel Dex, Attorney-in-Fact
2022-03-11